Literature DB >> 84091

Differences in cell surface antigens of tumor metastases and those of the local tumor.

M Fogel, E Gorelik, S Segal, M Feldman.   

Abstract

Tests were made to determine whether cell surface tumor antigens of metastases differed from the tumor antigens of the cell population of the local tumor growth. C57BL/6 mouse spleen lymphocytes sensitized against monolayers of the local growth of the 3LL Lewis lung carcinoma (L-3LL) in the presence of syngeneic serum generated lymphocytes that were cytotoxic to L-3LL but significantly less cytotoxic to target cells derived from lung metastases (M-3LL). Lymphocytes sensitized against M-3LL were significantly more cytotoxic against M-3LL than against L-3LL cells. Anti-M-3LL cytotoxic lymphocytes but not anti-L-3LL, admixed with either L-3LL cells or M-3LL tumor cells, when injected into syngeneic recipients reduced lung metastasis significantly. Results indicated that cells with high metastatic capacity and distinct antigenic properties exist within the tumor cell population and that immunoselection might be involved in the production of lung metastases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84091     DOI: 10.1093/jnci/62.3.585

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  25 in total

1.  Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.

Authors:  A Sacchi; G Piaggio; M A Rizzo; R Falcioni; S J Kennel
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

2.  Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells.

Authors:  P Brodt; M Feldman; S Segal
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

Authors:  J R Starkey; W C Davis; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Divergency between incidence of microscopic and macroscopic metastases.

Authors:  R Keller; M W Hess
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

5.  Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.

Authors:  D R Welch; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

6.  Monoclonal antibodies to Lewis lung carcinoma.

Authors:  S Ukei; I Saiki; I Azuma
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  Differences in lectin binding in tissue sections of human and murine malignant tumors and their metastases.

Authors:  H J Kahn; R Baumal
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

Review 8.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

9.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigen.

Authors:  A Sacchi; S Kennel; P G Natali; G Tibursi; C A Ghetti
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.